Free shipping on all orders over $ 500

AM1241

Cat. No. M2012

All AbMole products are for research use only, cannot be used for human consumption.

AM1241 Structure
Size Price Availability
10mg USD 100  USD100 Out of stock
50mg USD 300  USD300 Out of stock
100mg USD 450  USD450 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AM-1241 is a potent and selective agonist for the cannabinoid receptor CB2, with a Ki of 3.4nM at CB2 and 80x selectivity over the related CB1 receptor. AM1241 exhibits high affinity and selectivity for CB2 receptors. It also exhibits high potency in vivo. AM1241 dose-dependently reversed tactile and thermal hypersensitivity produced by ligation of the L5 and L6 spinal nerves in rats. AM1241 also inhibited flinching and thermal hyperalgesia produced by hind paw capsaicin injection. AM1241 was also active in blocking spinal nerve ligation-induced tactile and thermal hypersensitivity in mice lacking CB1 receptors (CB1-/- mice), confirming that AM1241 reverses sensory hypersensitivity independent of actions at CB1 receptors. Treatment with AM-1241 reduced both spontaneous and evoked pain, as well as reducing the bone loss and subsequent fractures due to the tumor.

Chemical Information
Molecular Weight 503.33
Formula C22H22IN3O3
CAS Number 444912-48-5
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Bingham B, et al. Br J Pharmacol. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.

[2] Shoemaker JL, et al. J Neurochem. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.

[3] Yao BB, et al. Br J Pharmacol. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

[4] Ibrahim MM, et al. Proc Natl Acad Sci U S A. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.

Related Cannabinoid Products
UCM707 

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of Anandamide.

SCH 336

SCH 336 is a potent, selective, inverse and orally active CB2 agonist.

JTE-907 

JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo.

LEI-101 

LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC50 of 8 for hCB2, and a pKi of less than 4 for hERG.

AEF0117 

AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi).

  Catalog
Abmole Inhibitor Catalog




Keywords: AM1241 supplier, Cannabinoid, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.